Panminerva medica
The most recent articles from:
Panminerva Med
-
Left atrial appendage closure: a new strategy for cardioembolic events despite oral anticoagulation.
Patients with non-valvular atrial fibrillation (nvAF) who experienced a cardioembolic (CE) event despite adequate oral anticoagulation (OAC) are at high risk of recurrence, and further prevention strategies are deemed necessary. The present study aimed to evaluate the safety and efficacy of off-label use of left atrial appendage closure (LAAC) in this subset of patients. ⋯ LAAC is a reasonable therapeutic option in nvAF patients who suffered a CE event despite adequate OAC therapy.